HAE · NYSE · Medical - Devices

Haemonetics

Blood-collection platforms and hospital devices for transfusion, surgery, and cardiac procedures.

$103.80
After-hours close−0.09 (−0.09%)
At close$103.89(−1.06%)

Breakdown13F · Form 4

Institutions 119.33%Insiders 1.42%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 45.45M · Float 44.84M · 98.7% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.5.91M13.00%13FAug 7, 2026
Neuberger Berman Group LLC4.18M9.20%13FAug 13, 2026
Vanguard Portfolio Management LLC2.55M5.60%13FAug 13, 2026
AQR Capital Management LLC2.27M4.99%13FAug 14, 2026
Ariel Investments, LLC2.06M4.53%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

341 holders · 54.23M shares · 56 new positions · 166 increased · 120 reduced · 48 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.5.91M13.00%+289.3KAug 7, 2026
Neuberger Berman Group LLC4.18M9.20%+618.5KAug 13, 2026
Vanguard Portfolio Management LLC2.55M5.60%−12.9KAug 13, 2026
AQR Capital Management LLC2.27M4.99%−1.09MAug 14, 2026
Ariel Investments, LLC2.06M4.53%+2.06MnewAug 14, 2026
Vanguard Capital Management LLC2.06M4.53%−30.8KAug 13, 2026
State Street Corp1.82M4.00%+45.3KAug 7, 2026
Dimensional Fund Advisors LP1.59M3.49%+259.2KAug 11, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
AQR Capital Management, LLC6.76%3.16M13GFeb 13, 2026
Vanguard Portfolio Management5.59%2.60M13GApr 29, 2026
Vanguard Capital Management5.26%2.45M13GApr 30, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Christopher Simondirector, officer: President & CEO366.4K0.81%May 19, 2026
Laurie A. Millerofficer: SVP, Human Resources41.0K0.09%Jun 8, 2026
Michelle L. Basilofficer: EVP and General Counsel40.4K0.09%May 19, 2026
Robert E. Abernathydirector27.5K0.06%Jul 28, 2026
Mark W. Krolldirector27.3K0.06%Jul 28, 2026
James DAreccaofficer: EVP, Chief Financial Officer25.1K0.06%May 19, 2026
Ellen M. Zanedirector21.9K0.05%Jul 28, 2026
Claire Pomeroydirector19.4K0.04%Jul 28, 2026
Michael J. Coyledirector17.9K0.04%Jul 28, 2026
Lloyd Emerson Johnsondirector15.5K0.03%Jul 28, 2026

3 ten-percent owners hold 16.6K shares by Form 4, outside the officers-and-directors figure above · 49 people have not refiled in the last 18 months (922.3K shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Nov 10, 2025
Mark W. Krolldirector
Purchase1,400$70.5624,757

CongressHouse and Senate disclosures

Not reported.